UK's Izana Bioscience tests rheumatoid arthritis drug in COVID-19 patients

UK-based biopharma company Izana Bioscience said it was testing its antibody therapy namilumab for the treatment of patients with rapidly worsening COVID-19 at the Humanitas Research Hospitals in Bergamo and Milan in Italy.

from Reuters: Health https://ift.tt/39Ps40N